Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.7100
+0.0197 (2.85%)
At close: Sep 10, 2026, 4:00 PM EDT
0.7150
+0.0050 (0.70%)
After-hours: Sep 10, 2026, 6:43 PM EDT
Envoy Medical Earnings Call Transcripts
Fiscal Year 2026
-
A fully implanted cochlear implant with unique sensor and battery design targets a large, underserved U.S. market. Clinical trials are fully enrolled, with FDA submission planned for next year and potential approval by late 2027. Strong IP, first-mover status, and strategic board additions position the company for significant disruption.
-
A fully implanted cochlear implant with unique sensor and chest battery aims to disrupt a large, underpenetrated market, offering invisible, 24/7 hearing and compatibility with wearables. Clinical trials are complete, FDA submission is planned for next year, and insurance coverage is in place.